Multi-center Korean cohort study based on RNA-sequencing data targeting COPD patients

In 2023, WHO ranked chronic obstructive pulmonary disease (COPD) as the third leading cause of death, with 3.23 million fatalities in 2019. The intricate nature of the disease, which is influenced by genetics, environment, and lifestyle, is evident. The effect of air pollution and changes in atmosph...

Full description

Saved in:
Bibliographic Details
Published in:Scientific data 2024-06, Vol.11 (1), p.593-9
Main Authors: Seo, Minseok, Park, Sinwoo, Kim, WooJin, Jung, Ji Ye, Bak, So Hyeon, Silverman, Edwin K., Park, Jinkyeong
Format: Article
Language:English
Subjects:
631/208
692/699/1785
Air pollution
Biomarkers
Chronic obstructive pulmonary disease
Cohort Studies
Coronaviruses
COVID-19
COVID-19 - genetics
Data Descriptor
Gene expression
Global warming
Humanities and Social Sciences
Humans
Lung diseases
multidisciplinary
Peripheral blood
Precision medicine
Pulmonary Disease, Chronic Obstructive - genetics
Republic of Korea
Respiratory tract diseases
Respiratory tract infection
Science
Science (multidisciplinary)
Sequence Analysis, RNA
Transcriptomes
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In 2023, WHO ranked chronic obstructive pulmonary disease (COPD) as the third leading cause of death, with 3.23 million fatalities in 2019. The intricate nature of the disease, which is influenced by genetics, environment, and lifestyle, is evident. The effect of air pollution and changes in atmospheric substances because of global warming highlight the need for this research. These environmental shifts are associated with the emergence of various respiratory infections such as COVID-19. RNA sequencing is pivotal in airway diseases, including COPD, as it enables comprehensive transcriptome analysis, biomarker discovery, and uncovers novel pathways. It facilitates personalized medicine by tracking dynamic changes in gene expression in response to various triggers. However, the limited research on East Asian populations may overlook the unique nuances of COPD development and progression. Bridging this gap and using peripheral blood samples for systemic analysis are crucial for comprehensive and globally applicable COPD diagnosis and treatment.
ISSN:2052-4463
2052-4463
DOI:10.1038/s41597-024-03389-8